Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close up 1.30%
09/18/2025 01:50 PM - Business
Nomura launches cross-border ETF listings in Taiwan, Japan
09/18/2025 01:45 PM - Society
Botulism, collisions top threats to migratory birds in Taiwan: MOA
09/18/2025 01:17 PM - Politics
Taiwan's newest Sky Bow missile system enters mass production: NCSIST
09/18/2025 01:08 PM - Culture
Sylvia Chang receives Camellia Award at Busan Film Festival
09/18/2025 12:04 PM